DayTwo is a microbiome-based precision health company committed to creating individualized solutions for the epidemic of chronic conditions, starting with diabetes, prediabetes, and clinical obesity.

Using the highest resolution microbiome analysis available and a unique artificial intelligence-based algorithm, DayTwo can accurately predict blood sugar response to foods or food combinations– before people even take a bite.

Its clinically proven approach is based on the company's proprietary microbiome dataset.

With over 85,000 samples, it is one of the largest and richest in the world.